Wound Imaging

MolecuLight i:X™ provides real time wound imaging at the point-of-care.

MolecuLight i:X™ for wound imaging

Wound imaging is a powerful technique for practitioners faced with the assessment of a non-healing (chronic) wound such as a diabetic foot ulcer or pressure ulcer. MolecuLight i:X is a novel wound assessment device providing real time imaging of bacteria and its distribution.

Real time wound imaging means prompt visualization and recognition of bacteria in wounds at the patient bedside. Stakeholders and practitioners including chiropodists, podiatrists, orthopedic surgeons, plastic surgeons and vascular surgeons are empowered by immediate access to bacteriological information in the palm of their hands.

MolecuLight i:X is a ground breaking development in wound assessment techniques and is making it possible for practitioners to make confident decisions on timely and suitable interventions that can impact patient lives early in their wound health. MolecuLight i:X can be used by practitioners in community-based hospitals and private clinics.

Clear benefits of MolecuLight i:X for wound imaging include:

• Instant visualization of bacteria
• Image guided sampling
• No patient contact
• No contrast agents
• Images/videos easily appended to patient’s file
• Intuitive, simple to use.

The Invisible is now visible

MolecuLight i:X can precisely target bacteria and its distribution in and around the wound. In clinical practice today, wound infection diagnosis relies on visual assessment of the wound under standard room lighting conditions. Yet the human eye cannot visualize bacteria in wounds. Wound imaging with MolecuLight i:X can visualize bacteria, in and around the wound, showing its presence and location. This portable and hand-held wound imaging device uses blue violet light to illuminate the wound area and records emitted light at wavelengths specific to pathogenic bacteria in and around the wound.

The practitioner sees a composite image of the recorded emission on a liquid colored display (LCD) at the point-of-care to make instantaneous assessment of the presence and location of clinically significant levels of bacteria. A successful clinical study showed that MolecuLight i:X can be used to guide and improve microbiological sampling and debridement of wounds in situ, enabling diagnosis, treatment guidance and response assessment in patients with chronic wounds ¹.

Wound imaging with MolecuLight i:X was investigated in a two center randomized clinical trial on chronic wounds ²; findings are published in the journal entitled Plos One ¹.

For more information on MolecuLight i:X for your practice, please contact us by -

E: info@moleculight.com

P: 647-362-4684

REFERENCES

1. DaCosta, R. S., Kulbatski, I., Lindvere-Teene, L., Starr, D., Blackmore, K., Silver, J. I., Linden, R. (2015). Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PloS One, 10(3), e0116623. http://doi.org/10.1371/journal.pone.0116623

2. DaCosta, R. S. et al; unpublished data, Clinical Trials.Gov NCT01378728, NCT01651845

3. Wu, Y. C., Smith, M., Chu, A., Lindvere-Teene, L., Starr, D., Tapang, K., DaCosta, R. S. (2015). Handheld fluorescence imaging device detects subclinical wound infection in an asymptomatic patient with chronic diabetic foot ulcer: a case report. International Wound Journal, n/a–n/a. http://doi.org/10.1111/iwj.12451